跳至主要内容
临床试验/NCT02673788
NCT02673788Unknown不适用

Follow-Up Study of Safety of Pneumostem® in Premature Infants With Intraventricular Hemorrhage

Samsung Medical Center1 个研究点 分布在 1 个国家目标入组 9 人开始时间: 2016年1月最近更新:
适应症

试验速览

阶段
不适用
入组人数
9
试验地点
1
主要终点
newly developed brain tumor

研究概览

简要总结

This is a follow-up study of the open label, single-center, phase I clinical trial to evaluate the safety of Pneumostem® in premature infants with Intraventricular hemorrhage.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
6 Months 至 2 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Patients who enrolled in the previous phase 1 clinical trial of Pneumostem transplantation for IVH.

排除标准

  • Patients who did not enrolled in the previous phase 1 clinical trial of Pneumostem transplantation for IVH.

结局指标

主要结局

newly developed brain tumor

时间窗: until 2 years old (corrected age)

Using brain MRI, it is to assess the risk of tumorigenicity of donor stem cells.

次要结局

  • Developmental disability(until 2 years old (corrected age))
  • Bayley score (MDI, PDI)(until 2 years old (corrected age))
  • Cerebral palsy(until 2 years old (corrected age))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Won Soon Park

Professor

Samsung Medical Center

研究点 (1)

Loading locations...

相似试验